About Pragya Pandey
Pragya is an equity research analyst and financial journalist with a passion for investing. In college she majored in finance and is currently pursuing the CFA program and is a Level II candidate.
When analyzing stocks, Pragya takes a fundamental approach and focuses on measuring a company's intrinsic value. Her goal is to help retail investors create successful portfolios to achieve financial success.
Recent Articles By Pragya Pandey
2 Small-Cap Tech Stocks Wall Street Forecasts Will Rally by 50% or More
The technology sector has been attracting significant investor attention owing to an increasing reliance on technology solutions. Furthermore, the Federal Reserve's reaffirmation that interest rates will remain unchanged in the near term has created a positive outlook for small-cap tech companies such as Impinj (PI) and ZIX Corporation (ZIXI). So, Wall Street analysts are bullish about these two stocks and expect them to rally by more than 50% in the coming months. Let’s discuss.
Like Tacos? These Check Out These 4 Buy-Rated Mexican Restaurant Stocks
As people resume face-to-face socializing, with nearly half of the U.S. population now fully vaccinated, restaurant operators are generating significant revenue growth. Cases in point are popular Mexican fast-food giants Chipotle Mexican Grill (CMG), Yum! Brands (YUM), Fiesta Restaurant (FRGI), and Del Taco Restaurant (TACO). We believe they are poised to capitalize on the industry’s steady recovery. So, these stocks could be solid bets now.
2 Top Nanotech Stocks to Buy for the Second Half of 2021
The demand for nanotechnology is growing with its numerous applications in industries from healthcare to agriculture. Because many countries and companies are increasingly focusing on nanoscience and nanotechnology innovations to drive some of the world’s biggest breakthroughs, the industry holds solid growth prospects. So, we believe nanotech stocks Thermo Fisher Scientific (TMO) and Onto Innovations (ONTO) are good bets now. Read on.
Scoop Up These 3 Under the Radar Stocks Trading Below $10
A spike in coronavirus infections worldwide due to the rapid spread of the Delta variant, and rising consumer prices, could lead to a broader market sell-off in the near term. Amid this volatile environment, because overpriced mega players are more likely to witness a correction, we believe it would be prudent to bet on relatively lesser-known stocks, such as H & M Hennes & Mauritz (HNNMY), CEMEX (CX), and Mazda Motor (MZDAY). They are each currently trading below $10 and have the potential to generate substantial returns. Let’s take a close look at these names.
2 A-Rated Medical Device Stocks to Add to Your Watchlist
Although the medical devices industry faced unprecedented challenges presented by the COVID-19 pandemic last year, it has bounced back this year thanks to increasing immunization rates. A recovery in demand for elective and essential surgical procedures, and rapid innovations, have bolstered the industry's growth potential. As such, we think that medical devices stocks Hill-Rom (HRC) and Integra LifeSciences (IART)—which are rated A in our proprietary stock-rating system—could be solid additions to one’s watchlist.
3 Under the Radar Construction Stocks to Buy Before an Infrastructure Deal is Announced
President Biden’s infrastructure bill proposal to revive the country’s infrastructure should bolster the construction industry's prospects. Although a failed Senate test vote recently dealt the bill a blow, Senators’ plans to advance the bill’s bipartisan framework in the coming days bodes well for construction stocks. Thus, we believe investing in the stock of relatively unsung construction companies Quanta Services (PWR), EMCOR Group (EME), and Granite Construction (GVA) could be highly rewarding. Let’s discuss.
2 Biotech Stocks to Buy for Outsized Gains
Biotech companies have experienced exponential growth over the past year owing to their contribution to efforts to combat the COVID-19 pandemic. The rising demand for medicines and therapies for treating several other critical diseases and significant breakthroughs in developing customized drugs are expected now to boost the industry’s growth further. So, we believe fundamentally strong biotech stocks Genmab (GMAB) and Bio-Techne have plenty of upside potential. Read on.
4 Mid-Cap Semiconductor Stocks That Have More Room to Run
The semiconductor industry is seeing a substantial uptick in demand from the consumer electronics and automotive industries. Consequently, we think semiconductor companies Rohm (ROHCY), Cirrus Logic (CRUS), MACOM Technology (MTSI), and Semtech (SMTC) have robust growth potential because they have been rapidly boosting their production levels. So, there could be plenty more upside to be had from these mid-cap stocks. Let’s discuss.
2 Beauty Stocks to Buy to Make Your Portfolio More Attractive
As people return to socializing and in-store shopping, with most of the U.S. population now having been at least partly vaccinated for COVID-19, beauty retailers are experiencing a significant increase in-store sales. Also, increased demand for personal care and elevated consumer awareness about organic skincare products are expected to boost the industry’s growth prospects further. So, we think beauty retailer stocks Ulta Beauty (ULTA) and Sally Beauty (SBH) could be great bets now.